title: Long-term disease-free survival in a primary plasma cell leukemia treated by VAD, autologous PBSC transplantation, and IFN-alpha.
authors.forename: Tomas
authors.initials: T
authors.lastname: Büchler
authors.forename: Christelle
authors.initials: C
authors.lastname: Ferra
authors.forename: Alicia
authors.initials: A
authors.lastname: Domingo
authors.forename: David
authors.initials: D
authors.lastname: Gallardo
authors.forename: Josep
authors.initials: J
authors.lastname: Sarra
authors.forename: Alberto
authors.initials: A
authors.lastname: Grańena
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007952:Leukemia, Plasma Cell / Q000188:drug therapy / Q000628:therapy*; D008875:Middle Aged; D012074:Remission Induction; D017741:Survivors; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D016898:Interferon-alpha; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin